Results for characterisation translation from Finnish to English

cf characterisation factor, karakterisointikerroin
cfcs chlorofluorocarbons

identification, collection, treatment, characterisation.
identification, collection, treatment, characterisation.

report i: characterisation factors, 1. painos.
report i: characterisation factors, first edition.

usetox – the unep-setac toxicity model: recommended characterisation factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment.
usetox - the unep-setac toxicity model: recommended characterisation factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment.

laboratori eni tecnologien ja isprassa sijaitsevan euroopan komission yhteisen tutkimuskeskuksen tekemät tutkimukset (esimerkiksi toimen 2113 – emissions characterisation and inventories osana tehty tutkimus).
studies carried out by laboratori eni tecnologie and the european commission’s joint research centre in ispra (for example, research undertaken within action 2113 – emissions characterisation and inventories).

konferenssin julkaisu, nro cg­14­98­962­en­c, 515 s., 19 6'. seafloor characterisation — ses­sion report, nro cg­15­98­099­en­c. 134 s., 10 €.
marine science and technology (mast iii) 1994-vs: cat.: cg-na-i8-i76-en-c, 63 pp.. €8.5.

cpmp: n luonnonlääkevalmisteiden työryhmä asiakirjan nimi note for guidance on non-clinical testing of herbal drug preparations with long-term marketing experience -guidance facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/bioequivalence of herbal drugs/preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing a -and -asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products
note for guidance on non-clinical testing of herbal drug preparations with long-term marketing experience -guidance to facilitate mutual recognition and use of bibliographic dataconcept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/bioequivalence of herbal drugs/preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol